Clinical Trial Detail

NCT ID NCT02797470
Title Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors AIDS Malignancy Consortium
Indications

mantle cell lymphoma

peripheral T-cell lymphoma

non-Hodgkin lymphoma

Hodgkin's lymphoma

follicular lymphoma

Burkitt lymphoma

Therapies

Carmustine + CCR5 shRNA/TRIM5a/TAR decoy-transduced CD34+ HPCs + Cytarabine + Etoposide + Melphalan

Age Groups: adult senior

Additional content available in CKB BOOST